Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Ramosetron on Late PONV (Postoperative Nausea and Vomiting) [Phase 4]
Phase 4 trial update on Ramosetron for postoperative nausea and vomiting in female breast cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway [Phase 2]
Phase 2 clinical trial update for RC48-ADC targeting HER2-expressing metastatic breast cancer with PAM pathway activation.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of F16IL2 with paclitaxel in solid tumors, including breast cancer, completed.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer [Phase 2]
Phase 2 trial evaluating neratinib with or without fulvestrant in metastatic HER2 non-amplified but HER2-mutant breast cancer has completed …
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer [Phase 2]
Phase 2 study of SPI-2012 or Pegfilgrastim for managing neutropenia in breast cancer has completed; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer [Phase 3]
Phase 3 trial comparing docetaxel and cyclophosphamide to anthracycline-based chemotherapy in HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer [Phase 4]
Phase 4 trial update comparing AC vs TC in HR-positive, HER2-negative early breast cancer; status and results are currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: PALbociclib CoLlaborative Adjuvant Study [Phase 3]
Phase 3 trial evaluating palbociclib as adjuvant therapy for breast cancer is not currently recruiting, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy [Phase 2]
Phase 2 clinical trial update for HR-positive, HER2-negative advanced breast cancer after progression on endocrine therapy.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib maleate combined with vinorelbine for HER2-positive advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Tranexamic Acid for Alloplastic Breast Reconstruction [Phase 3]
Phase 3 trial update evaluating tranexamic acid for reducing hematoma in alloplastic breast reconstruction.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Phase II Study of Everolimus Beyond Progression [Phase 2]
Phase II trial evaluating Everolimus beyond progression in breast cancer was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer [Phase 3]
Phase 3 randomized trial evaluating carboplatin and paclitaxel with or without veliparib in HER2-negative metastatic or locally advanced unr…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery [Phase 2]
Phase 2 trial comparing PECS block with multimodal analgesia to prevent persistent postoperative pain after breast surgery; results were pos…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer [Phase 2]
Phase 2 clinical trial assessing neoadjuvant therapy with pyrotinib, trastuzumab, pertuzumab, and nab-paclitaxel for HER2-positive breast ca…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction [Phase 3]
Phase 3 clinical trial update on immunonutrition and carbohydrate loading strategies in breast reconstruction following mastectomy; study co…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive [Phase 1, Phase 2]
Phase 1/2 trial update on a T cell receptor therapy targeting MAGE-A3 in HLA-DP0401 positive metastatic cancer; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer [Phase 3]
Phase 3 study evaluating atezolizumab or placebo in combination with neoadjuvant doxorubicin + cyclophosphamide followed by paclitaxel + tra…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of KD019 and trastuzumab in HER2-positive metastatic breast cancer, terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients [Phase 1, Phase 2]
Clinical trial update evaluating Immunopheresis alone or with chemotherapy versus chemotherapy alone in advanced breast cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery: [Phase 2]
Phase 2 clinical trial completed evaluating IV lidocaine for patients undergoing primary breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) [Phase 2]
Phase 2 trial of trilaciclib in combination with gemcitabine and carboplatin in metastatic triple-negative breast cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer [Phase 4]
A Phase 4 clinical trial update on Inetetamab combined with anti-PD-1 antibody and albumin-bound paclitaxel for HER2-positive metastatic bre…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Study of Preoperative Boost Radiotherapy [NA]
A terminated clinical trial studying preoperative boost radiotherapy for breast cancer with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) [Phase 1, Phase 2]
Phase 1/2 trial update for an ER+/HER2- breast cancer candidate (ENZENO) in locally advanced or metastatic disease; current status unknown.